Variant report
Variant | nsv968913 |
---|---|
Chromosome Location | chr5:52495296-52509384 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:246)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr5:52496378-52496405 | K562 | blood: | n/a | n/a |
2 | BATF | chr5:52507674-52507927 | GM12878 | blood: | n/a | chr5:52507794-52507805 |
3 | BATF | chr5:52507703-52507918 | GM12878 | blood: | n/a | chr5:52507794-52507805 |
4 | BHLHE40 | chr5:52497763-52497949 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr5:52500077-52500200 | K562 | blood: | n/a | chr5:52500137-52500148 |
6 | CEBPB | chr5:52500030-52500264 | HepG2 | liver: | n/a | chr5:52500137-52500148 |
7 | CEBPB | chr5:52495844-52495875 | H1-hESC | embryonic stem cell: | n/a | chr5:52495858-52495869 |
8 | CEBPB | chr5:52495713-52496009 | K562 | blood: | n/a | chr5:52495858-52495869 |
9 | CEBPB | chr5:52507773-52507830 | IMR90 | lung: | n/a | n/a |
10 | CEBPB | chr5:52495710-52495995 | A549 | lung: | n/a | chr5:52495858-52495869 |
11 | CEBPB | chr5:52495715-52496023 | HepG2 | liver: | n/a | chr5:52495858-52495869 |
12 | CEBPB | chr5:52495712-52496013 | IMR90 | lung: | n/a | chr5:52495858-52495869 |
13 | CEBPB | chr5:52495675-52496056 | Hela-S3 | cervix: | n/a | chr5:52495858-52495869 |
14 | CTCF | chr5:52497740-52497890 | GM12874 | blood: | n/a | n/a |
15 | CTCF | chr5:52507734-52507800 | A549 | lung: | n/a | n/a |
16 | CTCF | chr5:52497660-52497810 | SK-N-SH_RA | brain: | n/a | n/a |
17 | CTCF | chr5:52497676-52497861 | HepG2 | liver: | n/a | n/a |
18 | CTCF | chr5:52497720-52497870 | HEEpiC | esophagus: | n/a | n/a |
19 | CTCF | chr5:52497680-52497830 | BE2_C | brain: | n/a | n/a |
20 | CTCF | chr5:52497640-52497790 | AoAF | blood vessel: | n/a | n/a |
21 | CTCF | chr5:52497682-52497840 | GM19239 | blood: | n/a | n/a |
22 | CTCF | chr5:52507698-52507830 | Hela-S3 | cervix: | n/a | n/a |
23 | CTCF | chr5:52497640-52497790 | BJ | skin: | n/a | n/a |
24 | CTCF | chr5:52497660-52497810 | GM12869 | blood: | n/a | n/a |
25 | CTCF | chr5:52497572-52497910 | K562 | blood: | n/a | n/a |
26 | CTCF | chr5:52497680-52497830 | HCT-116 | colon: | n/a | n/a |
27 | CTCF | chr5:52497680-52497830 | GM12864 | blood: | n/a | n/a |
28 | CTCF | chr5:52497660-52497810 | HVMF | connective: | n/a | n/a |
29 | CTCF | chr5:52497740-52497890 | HRPEpiC | eye: | n/a | n/a |
30 | CTCF | chr5:52497680-52497830 | HEK293 | kidney: | n/a | n/a |
31 | CTCF | chr5:52497640-52497790 | HBMEC | blood vessel: | n/a | n/a |
32 | CTCF | chr5:52507730-52507816 | GM19239 | blood: | n/a | n/a |
33 | CTCF | chr5:52497717-52497817 | GM10266 | blood: | n/a | n/a |
34 | CTCF | chr5:52497681-52497844 | MCF-7 | breast: | n/a | n/a |
35 | CTCF | chr5:52497700-52497850 | Hela-S3 | cervix: | n/a | n/a |
36 | CTCF | chr5:52497722-52497772 | GM10248 | blood: | n/a | n/a |
37 | CTCF | chr5:52497511-52497903 | A549 | lung: | n/a | n/a |
38 | CTCF | chr5:52497680-52497830 | HVMF | connective: | n/a | n/a |
39 | CTCF | chr5:52497660-52497810 | HPF | lung: | n/a | n/a |
40 | CTCF | chr5:52497680-52497830 | RPTEC | kidney: | n/a | n/a |
41 | CTCF | chr5:52507720-52507870 | HepG2 | liver: | n/a | n/a |
42 | CTCF | chr5:52497720-52497870 | HMF | breast: | n/a | n/a |
43 | CTCF | chr5:52497700-52497850 | GM12868 | blood: | n/a | n/a |
44 | CTCF | chr5:52497640-52497790 | GM12865 | blood: | n/a | n/a |
45 | CTCF | chr5:52497720-52497870 | NHEK | skin: | n/a | n/a |
46 | CTCF | chr5:52497666-52497824 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | CTCF | chr5:52497720-52497870 | AoAF | blood vessel: | n/a | n/a |
48 | CTCF | chr5:52497680-52497830 | GM12875 | blood: | n/a | n/a |
49 | CTCF | chr5:52497622-52497863 | HepG2 | liver: | n/a | n/a |
50 | CTCF | chr5:52497692-52497826 | GM12891 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:52419531..52420160-chr5:52497344..52497892,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000213940 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10471842 | chr5:52495345-52495346 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs13153694 | chr5:52495361-52495362 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs539204394 | chr5:52495372-52495373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112044336 | chr5:52495373-52495374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375776495 | chr5:52495374-52495375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs71598836 | chr5:52495375-52495376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35614575 | chr5:52495396-52495397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs173844 | chr5:52495401-52495402 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs76554215 | chr5:52495416-52495417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369231407 | chr5:52495454-52495455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185059061 | chr5:52495536-52495537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187424309 | chr5:52495559-52495560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562554690 | chr5:52495652-52495653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77057808 | chr5:52495657-52495658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533007960 | chr5:52495661-52495662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs254481 | chr5:52495682-52495683 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs560227422 | chr5:52495683-52495684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369791907 | chr5:52495714-52495715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565971451 | chr5:52495744-52495745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs145282718 | chr5:52495793-52495794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10471843 | chr5:52495801-52495802 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs574764505 | chr5:52495830-52495831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567341357 | chr5:52495838-52495839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539640153 | chr5:52495926-52495927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531584303 | chr5:52495949-52495950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549892835 | chr5:52495982-52495983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571406359 | chr5:52495983-52495984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538905066 | chr5:52496044-52496045 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552077935 | chr5:52496067-52496068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554354441 | chr5:52496078-52496079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566095836 | chr5:52496118-52496119 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192323919 | chr5:52496146-52496147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs184714946 | chr5:52496201-52496202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142481859 | chr5:52496223-52496224 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528033057 | chr5:52496226-52496227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573713538 | chr5:52496236-52496237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189500290 | chr5:52496257-52496258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145092444 | chr5:52496273-52496274 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570236799 | chr5:52496291-52496292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577656020 | chr5:52496320-52496321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534694147 | chr5:52496324-52496325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs117486285 | chr5:52496328-52496329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs180832049 | chr5:52496338-52496339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184623793 | chr5:52496352-52496353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189493917 | chr5:52496389-52496390 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537469511 | chr5:52496398-52496399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368951629 | chr5:52496409-52496410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113551206 | chr5:52496414-52496415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531644629 | chr5:52496421-52496422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs117829992 | chr5:52496427-52496428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:52489000-52507000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr5:52489600-52507800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr5:52491000-52496000 | Weak transcription | Hela-S3 | cervix |
4 | chr5:52495200-52496000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr5:52496000-52496400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr5:52496000-52496400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr5:52496000-52496400 | Enhancers | Fetal Lung | lung |
8 | chr5:52496000-52496400 | Enhancers | Dnd41 | blood |
9 | chr5:52496000-52496600 | Enhancers | Adipose Nuclei | Adipose |
10 | chr5:52496000-52496800 | Enhancers | Hela-S3 | cervix |
11 | chr5:52506800-52508200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr5:52506800-52508200 | Enhancers | HMEC | breast |
13 | chr5:52506800-52508200 | Enhancers | NHEK | skin |
14 | chr5:52507000-52507400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr5:52507000-52507400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr5:52507000-52508200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr5:52507400-52507800 | Enhancers | HUVEC | blood vessel |
18 | chr5:52507400-52508200 | Enhancers | Muscle Satellite Cultured Cells | -- |
19 | chr5:52507400-52508200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
20 | chr5:52507400-52508400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr5:52507800-52508000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
22 | chr5:52508200-52508400 | ZNF genes & repeats | Foreskin Keratinocyte Primary Cells skin02 | Skin |
23 | chr5:52508200-52509600 | ZNF genes & repeats | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |